About Us

Point4 Biotechnologies, founded in 1998, is a privately held R&D and manufacturing company focused on the discovery, development and commercialization of pharmaceutical and health beneficiary  products that address significant clinical needs. 

Using high tech pharmaceutical and drug delivery system technologies, Point4 Biotechnologies combines the power of biological selection with the advantages of medicinal chemistry in a unique molecular evolution process  in the development of;

Point4Life™,  its drug candidate for adjuvant -supportive treatment of non-organ-specific-cancer and rapidly advancing lethal diseases, related-Fatigue,  

Point4Energy™  a unique  "anti-stress" protection against development and/or progression of non-specific-stress-related-diseases including cancer, and  

P4-NHI™ (Natural health ingredients) developed for the rapidly emerging functional food industry.

Point4 Biotechnologies also has clinical programs in HIV (AIDS), CFS (Chronic Fatigue Syndrome) and has other programs in the research or preclinical development stage.